175 related articles for article (PubMed ID: 35678885)
1. Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1.
Das JK; Deoraj A; Roy D; Felty Q
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2881-2891. PubMed ID: 35678885
[TBL] [Abstract][Full Text] [Related]
2. PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions.
Das JK; Felty Q
PLoS One; 2014; 9(8):e104159. PubMed ID: 25090023
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of DNA Binding Protein 3 (ID3) and Nuclear Respiratory Factor 1 (NRF1) Mediated Transcriptional Gene Signatures are Associated with the Severity of Cerebral Amyloid Angiopathy.
Perez CM; Gong Z; Yoo C; Roy D; Deoraj A; Felty Q
Mol Neurobiol; 2024 Feb; 61(2):835-882. PubMed ID: 37668961
[TBL] [Abstract][Full Text] [Related]
4. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
5. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
6. ID3 contributes to the acquisition of molecular stem cell-like signature in microvascular endothelial cells: its implication for understanding microvascular diseases.
Das JK; Voelkel NF; Felty Q
Microvasc Res; 2015 Mar; 98():126-38. PubMed ID: 25665868
[TBL] [Abstract][Full Text] [Related]
7. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
[TBL] [Abstract][Full Text] [Related]
8. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Respiratory Factor 1 Acting as an Oncoprotein Drives Estrogen-Induced Breast Carcinogenesis.
Das JK; Felty Q; Poppiti R; Jackson RM; Roy D
Cells; 2018 Nov; 7(12):. PubMed ID: 30486409
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
11. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
13. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
15. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.
Verdura S; Encinar JA; Gratchev A; Llop-Hernández À; López J; Serrano-Hervás E; Teixidor E; López-Bonet E; Martin-Castillo B; Micol V; Bosch-Barrera J; Cuyàs E; Menendez JA
Phytomedicine; 2024 Jun; 128():155493. PubMed ID: 38484626
[TBL] [Abstract][Full Text] [Related]
16. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
[TBL] [Abstract][Full Text] [Related]
17. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
[TBL] [Abstract][Full Text] [Related]
18. Low-dose phthalates promote breast cancer stem cell properties via the oncogene ΔNp63α and the Sonic hedgehog pathway.
Cao WS; Zhao MJ; Chen Y; Zhu JY; Xie CF; Li XT; Geng SS; Zhong CY; Fu JY; Wu JS
Ecotoxicol Environ Saf; 2023 Mar; 252():114605. PubMed ID: 36753971
[TBL] [Abstract][Full Text] [Related]
19. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
[TBL] [Abstract][Full Text] [Related]
20. Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism.
Liu Y; Zou T; Wang S; Chen H; Su D; Fu X; Zhang Q; Kang X
Int J Oncol; 2016 Mar; 48(3):1063-72. PubMed ID: 26794366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
